Jan 11, 2016 13:11 pm UTC| Business
LEESBURG, Va., Jan. 11, 2016 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M"), a global medical device company focused on designing, developing and commercializing innovative and...
StemCells, Inc. CEO Martin McGlynn Passes Baton to President and COO Ian Massey
Jan 11, 2016 13:05 pm UTC| Business
NEWARK, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of central nervous system disorders, today...
Jan 11, 2016 13:05 pm UTC| Business
-- Phase II Study in NSCLC in Collaboration with AstraZeneca Evaluating Bavituximab Plus Durvalumab to Expand Lung Cancer Program in Q1 2016 -- -- Phase II/III Study in HER2-Negative Metastatic Breast Cancer is Now...
ITG Releases December 2015 U.S. Trading Volumes
Jan 11, 2016 13:01 pm UTC| Business
NEW YORK, Jan. 11, 2016 (GLOBE NEWSWIRE) -- ITG (NYSE:ITG), a leading independent execution broker and financial technology provider, today announced that December 2015 U.S. trading volume was 2.8 billion shares and...
Jan 11, 2016 13:00 pm UTC| Business
EINDHOVEN, Netherlands, Jan. 11, 2016 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ:NXPI) announced today it will release financial results for the full-year and the fourth quarter of 2015 after the close of...
Xenon Outlines Key Milestones for 2016
Jan 11, 2016 13:00 pm UTC| Business
BURNABY, British Columbia, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today outlined its anticipated key corporate milestones for 2016. Dr....
Phase 3 Heart Failure Trial Size to be Substantially Reduced Following FDA Discussions
Jan 11, 2016 13:00 pm UTC| Business
NEW YORK and MELBOURNE, Australia, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) today announced that the size of the ongoing Phase 3 trial in chronic heart failure (CHF) of its proprietary...